System approaches to determine mechanisms underlying yeast replicative aging

描述（由申请人提供）：使用无脊椎生物已成为衰老研究的支柱，导致数百个衰老基因的鉴定。强调这些研究的实用性，至少有一些这些基因和途径在哺乳动物的寿命保守的影响。在评估进展情况时，显然需要采取一种新的、更加全系统的办法，以有效地向前迈进。在我们看来，有两个主要问题需要回答：（1）鉴于生物体中有数百个衰老基因，其中改变的表达与寿命延长有关，它们代表了多少种途径？如何描述它们？(2)在无脊椎动物衰老模型中，驱动衰老的机制是什么？它们是否保守？后一个问题一直顽固地顽固地拒绝在老龄化研究领域的各种方法。为了回答这两个问题，在这项提案中，三个具有互补专业知识的研究小组联合起来，使用高通量和最先进的方法相结合，全面了解酿酒酵母中的复制老化。Kennedy博士（与华盛顿大学的Matt Kaeberlein博士合作）刚刚完成了酵母ORF敲除的全基因组筛选，以提高复制寿命。在目标1中，我们将利用肯尼迪实验室的高通量能力开发最大的衰老上位性网络，以在功能上评估在一组代表性酵母衰老基因中延长寿命所需的下游途径。在Aim 2中，Li博士的研究小组将使用新开发的微流体系统来确定在长寿酵母突变体的背景下据称参与衰老的途径的状态，而在Aim 3中，Brem博士的研究小组将使用RNA测序来开发一系列长寿突变体的综合基因表达分析数据集。这后两种方法将有助于确定长寿突变体的细胞后果，并通过将其与目标1中的上位性研究相结合，我们将对复制性衰老产生全面的理解，确定所涉及的途径并朝着长寿的机制理解迈进。

DESCRIPTION (provided by applicant): The use of invertebrate organisms has become a mainstay of aging research, leading to the identification of hundreds of aging genes. Emphasizing the utility of these studies, at least some of these genes and pathways have conserved effects on longevity in mammals. In taking stock of the progress, it is clear that a new, more system wide approach is required to effective move forward. As we see it, there are two main questions that need to be answered: (1) Given that there are hundreds of aging genes, in which altered expression is associated with lifespan extension, in an organism, how many pathways do they represent and how can they be delineated?; (2) what are the mechanisms that drive aging in invertebrate aging models and are they conserved? This latter question has remained stubbornly refractory to a variety of approaches in the aging research field. With an eye toward answering these two questions, in this proposal three research groups with complementary expertise have joined forces to develop a comprehensive understanding of replicative aging in Saccharomyces cerevisiae using a combination of high throughput and state-of-the-art approaches. Dr. Kennedy (in collaboration with Dr. Matt Kaeberlein at the University of Washington) has just completed a genome-wide screen of yeast ORF knockouts for enhanced replicative lifespan. In Aim 1, we will develop the largest epistasis network of aging using the high-throughput capacity of the Kennedy lab to functionally assess which downstream pathways are required for lifespan extension in a set of representative yeast aging genes. In Aim 2, Dr. Li's research group will use a newly developed microfluidic system to determine the state of pathways purported to be involved in aging in the context of long-lived yeast mutants and in Aim 3, Dr. Brem's group will use RNA sequencing to develop a comprehensive gene expression analysis dataset in a range of long-lived mutants. These latter two approaches will help determine the cellular consequences of longevity mutants and by combing those with the epistasis studies in Aim 1, we will generate a comprehensive understanding of replicative aging, identifying the pathways involved and moving toward a mechanistic understanding of longevity.